Close

More on ACOR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-139.7% Growth)
- Ratings (2.3 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/7/23 *Est.)
- M&A (1/26/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ACOR Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 127.94M
Restricted cash
Short-term investments
Trade accounts receivable, net 48.58M
Prepaid expenses 15.64M
Finished goods inventory held by the Company
Finished goods inventory held by others
Other current assets 4.86M
Total current assets 237.95M
Property and equipment, net of accumulated depreciation 35.78M
Intangible assets, net of accumulated amortization 749.42M
Non-current portion of deferred cost of license revenue 2.43M
Other assets 5.81M
Total assets 1.32B
Current liabilities:
Accounts payable 18.56M
Accrued expenses and other current liabilities 89.37M
Deferred product revenue-Zanaflex tablets
Deferred product revenue-Zanaflex Capsules
Current portion of deferred license revenue 9.06M
Current portion of revenue interest liability
Current portion of convertible notes payable 1.13M
Total current liabilities 118.12M
Non-current portion of deferred license revenue 34.72M
Put/call liability
Non-current portion of revenue interest liability
Non-current portion of convertible notes payable 0
Stockholders' equity:
Common stock, $0.001 par value. Authorized 80,000,000 shares at June 30, 2011 and December 31, 2010; issued and outstanding 39,106,856 and 38,779,370 shares as of June 30, 2011 and December 31, 2010, respectively 46K
Treasury stock at cost (12,420 shares at June 30, 2011 and December 31, 2010) -329K
Additional paid-in capital 911.54M
Accumulated deficit -240.88M
Accumulated other comprehensive income -3.62M
Total stockholders' equity 666.77M
Total liabilities and stockholders' equity 1.32B